IS8105A - Lyfjablanda sem felur í sér ónæmisbæli til að nota í meðhöndlun á húðsjúkdómum - Google Patents

Lyfjablanda sem felur í sér ónæmisbæli til að nota í meðhöndlun á húðsjúkdómum

Info

Publication number
IS8105A
IS8105A IS8105A IS8105A IS8105A IS 8105 A IS8105 A IS 8105A IS 8105 A IS8105 A IS 8105A IS 8105 A IS8105 A IS 8105A IS 8105 A IS8105 A IS 8105A
Authority
IS
Iceland
Prior art keywords
immunosuppressant
treatment
pharmaceutical composition
composition including
skin disorders
Prior art date
Application number
IS8105A
Other languages
English (en)
Inventor
Hirsch Stefan
Karl Mayer Friedrich
Paul Carle
Sekkat Nabila
Weiss Carl-Martin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IS8105A publication Critical patent/IS8105A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS8105A 2003-04-04 2005-10-31 Lyfjablanda sem felur í sér ónæmisbæli til að nota í meðhöndlun á húðsjúkdómum IS8105A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307866.4A GB0307866D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition
PCT/EP2004/003513 WO2004087141A1 (en) 2003-04-04 2004-04-02 Pharmaceutical composition comprising an immunosuppressant for use in the treatment of skin diseases

Publications (1)

Publication Number Publication Date
IS8105A true IS8105A (is) 2005-10-31

Family

ID=9956229

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8105A IS8105A (is) 2003-04-04 2005-10-31 Lyfjablanda sem felur í sér ónæmisbæli til að nota í meðhöndlun á húðsjúkdómum

Country Status (13)

Country Link
US (1) US20070276004A1 (is)
EP (1) EP1613314A1 (is)
JP (1) JP2006522059A (is)
CN (1) CN1767826A (is)
AU (1) AU2004226821A1 (is)
BR (1) BRPI0409187A (is)
CA (1) CA2521250A1 (is)
GB (1) GB0307866D0 (is)
IS (1) IS8105A (is)
MX (2) MXPA05010708A (is)
NO (1) NO20055136L (is)
RS (1) RS20050739A (is)
WO (1) WO2004087141A1 (is)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0506139D0 (en) * 2005-03-24 2005-05-04 Transphase Ltd A transdermal topical composition and its uses
US9168383B2 (en) 2005-10-14 2015-10-27 Pacesetter, Inc. Leadless cardiac pacemaker with conducted communication
US8010209B2 (en) 2005-10-14 2011-08-30 Nanostim, Inc. Delivery system for implantable biostimulator
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2016935A1 (en) * 2007-07-09 2009-01-21 Intendis GmbH Pharmaceutical composition for topical application of poorly soluble compounds
US8527068B2 (en) 2009-02-02 2013-09-03 Nanostim, Inc. Leadless cardiac pacemaker with secondary fixation capability
US9060692B2 (en) 2010-10-12 2015-06-23 Pacesetter, Inc. Temperature sensor for a leadless cardiac pacemaker
EP2627403A4 (en) 2010-10-12 2014-03-26 Nanostim Inc Temperature sensor for a leadless cardiac pacemaker
US9020611B2 (en) 2010-10-13 2015-04-28 Pacesetter, Inc. Leadless cardiac pacemaker with anti-unscrewing feature
US9126032B2 (en) 2010-12-13 2015-09-08 Pacesetter, Inc. Pacemaker retrieval systems and methods
EP2651494B1 (en) 2010-12-13 2017-02-15 Pacesetter, Inc. Delivery catheter
CN103328040B (zh) 2010-12-20 2016-09-14 内诺斯蒂姆股份有限公司 具有径向固定机构的无导线起搏器
JP2014506936A (ja) * 2011-03-03 2014-03-20 アラーガン インコーポレイテッド シリコーンベースの眼科製剤
WO2013067496A2 (en) 2011-11-04 2013-05-10 Nanostim, Inc. Leadless cardiac pacemaker with integral battery and redundant welds
US9802054B2 (en) 2012-08-01 2017-10-31 Pacesetter, Inc. Biostimulator circuit with flying cell
JP2018513210A (ja) * 2015-03-25 2018-05-24 ゲーツェーテー ゲーエムベーハー 化粧品及び化粧品を製造するためのコンセントレート
CA3020157C (en) * 2016-04-04 2024-01-16 Drug Delivery Solutions Limited Topical composition comprising tacrolimus
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
JP2024544080A (ja) * 2021-12-16 2024-11-27 ザ プロクター アンド ギャンブル カンパニー ヘアコンディショニング組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08133979A (ja) * 1994-09-16 1996-05-28 Sando Yakuhin Kk 局所適用薬剤組成物
CN100335063C (zh) * 1994-10-26 2007-09-05 诺瓦蒂斯有限公司 药物组合物
GB2327610B (en) * 1994-11-04 1999-06-02 Novartis Ag Macrolide compositions
WO1997024112A1 (en) * 1995-12-28 1997-07-10 Yoshitomi Pharmaceutical Industries, Ltd. External preparation
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
PT1014916E (pt) * 1997-08-18 2002-06-28 Neubourg Stephanie Espuma creme de proteccao dermatologica
ME00189B (me) * 1998-03-26 2011-02-10 Astellas Pharma Inc Preparati sa neprekidnim oslobađanjem
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
JP2001064164A (ja) * 1999-06-23 2001-03-13 Health Science Center:Kk 止痒皮膚塗布剤
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
PE20030828A1 (es) * 2002-03-04 2003-11-04 Novartis Ag Composicion oftalmica que comprende ascomicina
GB0218996D0 (en) * 2002-08-14 2002-09-25 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
WO2004087141B1 (en) 2005-01-06
BRPI0409187A (pt) 2006-04-11
AU2004226821A1 (en) 2004-10-14
NO20055136L (no) 2006-01-04
NO20055136D0 (no) 2005-11-02
MXPA05010708A (es) 2005-12-12
CA2521250A1 (en) 2004-10-14
JP2006522059A (ja) 2006-09-28
MXPA05010703A (es) 2005-12-12
WO2004087141A1 (en) 2004-10-14
RS20050739A (sr) 2007-11-15
GB0307866D0 (en) 2003-05-14
EP1613314A1 (en) 2006-01-11
CN1767826A (zh) 2006-05-03
US20070276004A1 (en) 2007-11-29

Similar Documents

Publication Publication Date Title
IS8105A (is) Lyfjablanda sem felur í sér ónæmisbæli til að nota í meðhöndlun á húðsjúkdómum
CR8642A (es) Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos
IS7814A (is) Fenetanólamín afleiða í meðhöndlun á öndunarfærasjúkdómum.
AU2003286567A8 (en) Methods for the treatment of skin disorders
PT1485127E (pt) Administração de agentes para o tratamento de inflamação
IL183101A (en) Use of tetrahydrocannabivarin in drug production
PL378168A1 (pl) Dihydropterydynony, sposoby ich wytwarzania i ich zastosowanie w postaci leków
IS8142A (is) Læknislyf gagnleg til meðferðar á verkjum
PT1605956E (pt) Administração de capsaicinóides para o tratamento da osteoartrite
IL178775A (en) Pharmaceuticals containing glucocorticoid for use in the treatment of disorders requiring acute glucocorticoid therapy
IS7738A (is) Þíasól efnasambönd til notkunar í meðferð á taugahrörnunar truflunum.
DE60322451D1 (de) 4-Tetrazolyl-4-Phenylpiperidinderivate zur Schmerzbehandlung
AU2003228819A8 (en) Combinations for the treatment of inflammatory skin disorders
IL165394A0 (en) Use of thio-oxindole derivatives in treatment of skin disorders
IS7444A (is) Morfólínýl-þvagefna afleiður til notkunar við meðhöndlun á bólguvaldandi sjúkdómum
EP1684758A4 (en) METHODS AND COMPOSITIONS USING THALIDOMIDE FOR THE TREATMENT AND MANAGEMENT OF CANCERS AND OTHER DISEASES
SI1807156T1 (sl) Nove farmacevtske oblike za uporabo pri zdravljenju nespečnosti
EP1539100A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISORDERS
GB2411834B (en) Composition for use in the treatment of dry skin conditions
IS7868A (is) Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
ZA200609007B (en) Medical plaster for application on the skin
GB0310147D0 (en) A composition for use in the treatment of a skin condition in a subject
IL174968A0 (en) The use of ifenprodil in the treatment of pain
HK1111892A (en) Use of pyrazolyl-pyrimidine derivatives in the treatment of pain
ITVI20030042A1 (it) Dispositivo manuale per trattamento dermatologico ed estetico.